Microba Life Sciences Limited

Research Microba Life Sciences Limited (F3Y) on Bullrun: market cap EUR 12.96M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerF3Y
• ExchangeF
• CountryAustralia
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyEUR
• Market capEUR 12.96M
• Financial periodFY2025
• RevenueEUR 15.67M
• Revenue growth29.6%
• Net income-EUR 14.94M
• Free cash flow-EUR 14.91M
• Gross margin47.5%

Valuation Snapshot

latest market cap is EUR 12.96M.

About Microba Life Sciences Limited

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates in two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection;

Frequently asked questions

What is Microba Life Sciences Limited's market cap?

Microba Life Sciences Limited's market capitalization is EUR 12.96M.

What does Microba Life Sciences Limited do?

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland.